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Dendritic cell immunoreceptor 1 alters
neutrophil responses in the development
of experimental colitis
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Abstract
Background: Ulcerative colitis, an inflammatory bowel disease, is associated with the massive infiltration of
neutrophils. Although the initial infiltration of neutrophils is beneficial for killing bacteria, it is presumed that
persistent infiltration causes tissue damage by releasing antibacterial products as well as inflammatory cytokines.
A murine C-type lectin receptor, dendritic cell immunoreceptor 1 (Dcir1), is expressed on CD11b+ myeloid cells,
such as macrophages, dendritic cells and neutrophils. It was reported that Dcir1 is required to maintain homeostasis
of the immune system to prevent autoimmunity, but it is also involved in the development of infectious disease
resulting in the enhanced severity of cerebral malaria. However, the role of Dcir1 in intestinal immune responses
during colitis remains unclear. In this study, we investigated the role of Dcir1 in intestinal inflammation using an
experimental colitis model induced with dextran sodium sulfate (DSS).
Results: In contrast to wild type (WT) mice, Dcir1−/− mice exhibited mild body weight loss during the course of
DSS colitis accompanied by reduced colonic inflammation. Dcir1 deficiency caused a reduced accumulation of
neutrophils in the inflamed colon on day 5 of DSS colitis compared with WT mice. Consistently, the production of a
neutrophil-attracting chemokine, MIP-2, was also decreased in the Dcir1−/− colon compared with the WT colon on
day 5. There were fewer myeloperoxidase-positive neutrophils in the inflamed colon of Dcir1−/− mice than in that of
WT mice. Moreover, bone marrow neutrophils from Dcir1−/− mice produced less reactive oxygen species (ROS) by
lipopolysaccharide stimulation than those from WT mice. This suggests that Dcir1 deficiency decreases the
accumulation of tissue destructive neutrophils during DSS colitis.
Conclusion: Dcir1 enhances the pathogenesis of DSS colitis by altering neutrophil recruitment and their functions.
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Background
Inflammatory bowel disease (IBD) is an inflammatory
disorder of the gastrointestinal tract and is clinically sub-
divided into two forms: ulcerative colitis (UC) and
Crohn’s disease [1]. The disease is characterized by in-
flammation of the intestine, and the clinical symptoms
include weight loss, diarrhea accompanied by blood, and
abdominal pain [2, 3]. The affected areas typically show
transmural inflammation characterized by lymphoid
hyperplasia, submucosal edema, ulcerative lesions and fi-
brosis [2]. The etiology of IBD still remains largely un-
clear. In recent years, however, epidemiologic and
genetic studies in human and IBD-related animal models
have suggested that genetic susceptibility factors affect-
ing the host immune system and environmental factors
such as gut microbiota contribute to the initiation and
chronicity of IBD [4–6].
Neutrophils produce massive amounts of reactive oxy-
gen species (ROS) that effectively destroy pathogens [7]
and numerous antibacterial intracellular granules that
contain myeloperoxidase (MPO) among other molecules
[8]. Hypochlorous acid and other chlorinated oxidants
generated by a catalytic reaction between chloride and
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hydrogen peroxide by MPO result in tissue injury under
inflammatory conditions and protect from pathogenic in-
fection [8–10]. In the gut of IBD patients, the excessive re-
cruitment and accumulation of activated neutrophils were
observed in association with mucosal injury and debilitat-
ing disease symptoms [7]. IBD can be accelerated by in-
nate immune cells, which recognize pathogen-associated
and damage-associated molecular patterns through pat-
tern recognition receptors (PRRs) [11, 12].
Dendritic cell (DC) immunoreceptor (DCIR), a C-type
lectin receptor, is a PRR and is expressed on DCs,
monocytes, macrophages, B cells, and neutrophils in
humans [13, 14]. The cytoplasmic tail of DCIR contains
an immunoreceptor tyrosine-based inhibitory motif
(ITIM), which transduces immunoregulatory signals via
interactions with Src homology 2 domain tyrosine phos-
phatase (SHP)-1 and SHP-2 [14]. Similar to other C-type
lectin receptors such as Mincle, which is expressed on
macrophages and recognizes pathogen-associated mo-
lecular patterns and damage-associated molecular pat-
terns to initiate an immune response [15], DCIR can
bind to endogenous carbohydrates as well as pathogenic
and viral antigens [16, 17].
In mice, Dcir consists of four homologs (Dcir1 to 4).
Although Dcir1 and Dcir2 contain ITIM sequences, only
Dcir1 has been shown to interact with SHP-1 and SHP-
2 [14, 18]. Several studies showed that murine Dcir1 is
also expressed on CD11b+ myeloid cells, including
monocytes, macrophages, and DCs; however, Dcir2 is
mainly expressed on CD8− DCs [14, 16, 19]. We recently
reported that a lack of Dcir1 exacerbated autoimmune
arthritis caused by the spontaneous expansion and acti-
vation of DCs [20]. Other studies demonstrated that
Dcir1 was essential for the development of cerebral mal-
aria and that Dcir1 deficiency reduced brain inflamma-
tion accompanied with decreased tumor necrosis factor
(TNF)-α production and modulated the activation of T
cells [21]. These results suggest that Dcir1 is involved in
disease symptoms both positively and negatively.
Infiltration by neutrophils and monocytes is a charac-
teristic histologic feature of lesions of active UC [22].
Neutrophils and Ly6Chi monocytes are considered to pro-
mote intestinal inflammation during acute dextran sulfate
sodium (DSS) induced colitis (DSS colitis) [23, 24]; there-
fore, we hypothesized that Dcir1 may have an effect on
the symptoms of colitis by altering the behavior and func-
tions of these cells.
This study examined the effect of Dcir1 deficiency in
intestinal inflammation using a DSS colitis model. We
found that Dcir1−/− mice developed milder colitis with
low accumulation of activated neutrophils and expres-
sion of macrophage inflammatory protein-2 (MIP-2) in
the colon than WT mice. Neutrophils from Dcir1−/−
bone marrow also had less ROS production in response
to lipopolysaccharide (LPS) than those from WT mice.
In conclusion, our data suggest that Dcir1 is responsible
for the development of acute colitis by promoting neu-
trophil recruitment and altering neutrophil functions.
Methods
Mice
C57BL/6 mice were purchased from Japan SLC (Hama-
matsu, Japan). Dcir1-deficient (Dcir1−/−) mice on a
C57BL/6 background [20] were obtained from Dr. Iwakura
(Tokyo University of Science, Chiba, Japan). All mice used
in this study were female and aged between 8 and 10 weeks.
Dcir1−/− or C57BL/6 wild type (WT) control mice were co-
housed after weaning until use. All experiments were per-
formed according to the Institutional Guidelines for Animal
Use and Experimentation of Kyoto University (Permit
Number: Lif-K13020).
DSS colitis
Dcir1−/− or WT mice were provided with 2.0 % (wt/vol)
DSS (reagent grade DSS salt; molecular mass = 36–50 kDa)
(MP Biomedicals, Irvine, CA) dissolved in drinking water
for 5 days, followed by 3 days with normal water. Mice
given normal water for the entire period were used as con-
trols. Individual mouse body weight was recorded daily for
each group. On day 8, the length of the cecum and colon
was measured after dissection by placing them on a paper
towel.
Histological analysis
After washing in phosphate buffered saline (PBS), the
cecum and colon were cut longitudinally and fixed with
Bouin’s solution (71.4 % saturated picric acid, 23.8 % for-
maldehyde, and 4.8 % acetic acid) for 2 h at room
temperature and embedded in paraffin. Two sections
(4–6 μm thick) from a remote area of the cecum, and
sections from the descending, transverse, and ascending
colon from individual mice were stained with
hematoxylin-eosin (HE) and observed using a BZ-8000
Biozero imaging device (Keyence, Osaka, Japan).
Histological colitis scores were determined as previ-
ously described [25]. Briefly, subscores were as follows:
ulceration: 0, no ulcers; 1, one ulcer; 2, two ulcers; 3,
three ulcers; and 4, > 3 ulcers: epithelium: 0, normal
morphology; 1, loss of goblet cells; 2, loss of goblet cells
in large areas; 3, loss of crypts; and 4, loss of crypts in
large areas (>50 %) and/or foci of polypoid regeneration:
infiltration: 0, no infiltrate; 1, infiltrate around crypt
bases; 2, infiltrate reaching to lamina muscularis mu-
cosae; 3, extensive infiltration reaching lamina muscu-
laris mucosae, thickening of the mucosa with abundant
edema; and 4, infiltration of the lamina submucosa:
lymphoid follicles: 0, no lymphoid follicles; 1, one
lymphoid follicle; 2, two lymphoid follicles; 3, three
Tokieda et al. BMC Immunology  (2015) 16:64 Page 2 of 11
lymphoid follicles; and 4, > 3 lymphoid follicles. The col-
itis score of each mouse represents the mean of the dif-
ferent histological subscores.
For the immunohistological detection of neutrophils,
10-μm-thick frozen sections from DSS-treated WT and
Dcir1−/− colonic tissues were fixed with 4 % parafor-
maldehyde, and stained with rabbit anti-MPO poly-
clonal antibody (Ab) (Abcam, Cambridge, MA)
followed by incubation with donkey-anti rabbit IgG-
Cy3 (BioLegend, San Diego, CA) and then with anti-
Ly6G-FITC (BD Biosciences, San Jose, CA), anti-CD11b-
APC (eBioscience, San Diego, CA) and DAPI (Wako Pure
Chemical Industries, Ltd., Osaka, Japan). After refixation
with 1 % paraformaldehyde for 10 min, the specimens
were mounted with Vectashield mounting medium
(Vector Laboratories, Burlingame, CA) and observed
using a deconvolution microscope BX51-FL (Olympus,
Tokyo, Japan). MPO+CD11b+Ly6G+ cells were counted
as activated neutrophils. Data represent number of neu-
trophils/whole area of a vertical section.
Isolation of mononuclear cells
Isolation of lamina propria mononuclear cells (LPMCs)
was performed as described previously [26] with some
modifications. Briefly, colons were opened longitudinally
and washed to remove fecal content by shaking in
Hank’s Balanced Salt Solution containing 5 mM EDTA
for 20 min at 37 °C, followed by the removal of epithelial
cells and fat tissue. After cutting the colon into small
pieces, tissues were incubated with RPMI 1640 contain-
ing 4 % fetal bovine serum (FBS), 1 mg/ml collagenase D
(Roche, Basel, Switzerland), 0.5 mg/ml dispase (Gibco,
Carlsbad, CA) and 40 μg/ml DNase (Sigma–Aldrich, St.
Louis, MO) for 50 min at 37 °C in a shaking water bath.
The digested tissues were washed with Hank’s Balanced
Salt Solution containing 5 mM EDTA, resuspended in
4 ml of 40 % Percoll (GE Healthcare, Tokyo, Japan) and
overlaid on 2 ml of 80 % Percoll in a 15 ml conical tube.
Percoll gradient separation was performed by centrifuga-
tion at 1200 × g for 20 min at 25 °C. The cells at the
interface were collected and used as LPMCs.
Flow cytometry
LPMCs suspended in staining buffer (PBS containing 1 %
FBS, 5 mM EDTA and 0.02 % NaN3) were incubated with
anti-CD16/32 monoclonal antibodies (mAb) for 30 min at
4 °C to block nonspecific binding. Then, cells were stained
for 30 min at 4 °C with a combination of the following
fluorescent mAbs: FITC-conjugated anti-Ly6G or anti-
DX5 (BD Biosciences), PE-conjugated anti-CD11c (BD
Biosciences), PE-Cy7-conjugated anti-CD11b (BD Biosci-
ences), Alexa Fluor 647-conjugated anti-Ly6C (BioLe-
gend), APC-conjugated anti-CD3ε (eBioscience) or anti-
CD19 (eBioscience). Dead cells were gated out by staining
with 7-aminoactinomycin D (7-AAD) (Life Technologies,
Carlsbad, CA). Stained cells were acquired using FACSCa-
libur (BD Biosciences) or FACSAriaIII (BD Biosciences),
and data were analyzed with FlowJo software (TreeStar
Inc., Ashland, OR).
Cytokine measurement
After treatment with DSS for 5 days, ceca and colons were
obtained from Dcir1−/− or WT mice. Colons were divided
into three pieces and ceca were washed and weighed. Each
segment was cultured in RPMI 1640 medium for 24 h, and
cytokines, interleukin (IL)-1β, IL-6, IL-10, IL-12, TNF-α
and monocyte chemoattractant protein-1 (MCP-1), in the
medium were measured using a cytometric bead array
(BD Biosciences) according to the manufacturer’s instruc-
tions. Data were analyzed with FCAP Array software (BD
Biosciences). Data were analyzed by FCAP Array software
(BD Biosciences). The concentrations of MIP-2 and KC
were measured by ELISA (PeproTech, Rocky Hill, NJ) ac-
cording to the manufacturer’s instructions.
Migration assay of neutrophils
Chemotactic activity of neutrophils was assessed using 3-
μm pore size transwells (Costar, Washington, DC). After re-
moving red blood cells with ACK lysis buffer (0.15 M
NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA, pH 7.2), bone
marrow cells were blocked with anti-CD16/32 mAb, and
stained with FITC-anti-Ly6G and PE-anti-CD11b mAbs
(eBioscience). Then, cell suspensions (106/well) in RPMI
1640 containing 0.1 % bovine serum albumin in the upper
well were placed above a lower well with or without
100 ng of MIP-2 (PeproTech). One hour later, input cells
and cells that had migrated into the lower well were
counted and analyzed by flow cytometry.
Neutrophil preparation and measurement of oxidative
burst
Ly6G+ CD11b+ cells in bone marrow were sorted as
neutrophils using FACSAriaIII. Purified neutrophils were
stimulated in the presence or absence of 100 ng/ml
Ultra-pure LPS from E. coli O111:B4 (InvivoGen, San
Diego, CA) or 10 ng/ml granulocyte-macrophage
colony-stimulating factor (GM-CSF) (Kirin Brewery,
Gunma, Japan) for 6 h, and then incubated with 10 μM
of dihydrorhodamine-123 (DHR-123) (Sigma–Aldrich)
for 30 min in quadruple cultures. Fluorescence intensity
was determined using FACSCalibur. Results were calcu-
lated according to the following formula: rhodamin-123
fluorescence =mean fluorescence intensity (MFI) of
stimulated cells/MFI of unstimulated cells × 100.
Statistical analysis
Differences between Dcir1−/− and WT groups or treated
and nontreated groups were evaluated using the unpaired
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Student’s t-test. A P-value of < 0.05 was considered
statistically significant.
Results
Milder symptoms of DSS colitis in Dcir1−/− compared with
WT mice
To elucidate the roles of Dcir1 in acute colitis, Dcir1−/−
and WT mice were treated with drinking water contain-
ing 2.0 % DSS for 5 days, followed by normal water for
3 days. DSS-treated WT and Dcir1−/− mice started losing
body weight on day 4 and day 5, respectively, and both
groups showed a gradual loss of weight thereafter
(Fig. 1a). Weight loss in DSS-treated WT mice was sig-
nificantly greater than that in Dcir1−/− mice from day 4,
but there was no significant difference in the colon
length of both groups (Fig. 1a, b).
Damage caused by ulceration and submucosal inflam-
mation was identified by disruption of the epithelial bar-
rier [27]. Histological analysis of the colons from
untreated Dcir1−/− mice showed intact epithelium, ab-
sence of edema, and normal muscle architecture (Fig. 1c).
However, on day 8 after the induction of colitis, Dcir1−/−
mice showed milder colon tissue damage than WT mice,
characterized by mucosal architecture, thickening of
smooth muscle, presence of crypt abscesses, and cellular
infiltration (Fig. 1c), particularly in the transverse and
descending colon (Fig. 1c, the third and bottom row). In
the cecum, increased mucosal erosion was observed in
both groups, but inflammatory cell infiltration was
greater in WT mice than in Dcir1−/− mice (Fig. 1c, top
row). The colitis scores of cecum and colon sections also
supported the macroscopic observations (Fig. 1d). These
data suggest that Dcir1 accelerates the development
and/or promotes acute colitis.
Decreased infiltration of neutrophils during DSS colitis in
Dcir1−/− mice compared with WT mice
Massive infiltration of various types of leukocytes in the
colon is often accompanied by the progression of DSS
colitis [28]. In Dcir1−/− mice, the infiltration of neutro-
phils into the colon was significantly lower than in WT
mice (Fig. 2a), especially on day 5 (Fig. 2b). At the same
time point, Ly6Chi, Ly6Cint, and Ly6Clo monocytic cells
were slightly decreased in Dcir1−/−mice compared with
WT mice, although this was not statistically significant.
Similarly, lower numbers of natural killer (NK) cells,
NKT cells and T cells, but not B cells, infiltrated the
colon in Dcir1−/−mice compared with WT mice on day
5, but this was not statistically significant (Fig. 2c and d).
Although both immuno-suppressive and -activating sub-
types were present in the infiltrating cells, it is known
that neutrophils are the first effector cells observed in
the colon during the onset of DSS colitis. Collectively,
these findings suggest that, in the Dcir1 expressing cells,
a decrease of neutrophils rather than of monocytes, con-
tributes to the amelioration of DSS colitis in Dcir1−/−
mice.
Decreased MIP-2 production in the intestine of Dcir1−/− mice
We next checked cytokine/chemokine production in
Dcir1−/− and WT mouse intestines using a whole tissue
culture method [29, 30]. Notably, on day 5 of DSS treat-
ment, neutrophil chemoattractant MIP-2, not but KC,
production in the colon and cecum of Dcir1−/− mice was
significantly lower than in WT mice, consistent with the
reduced accumulation of neutrophils in the Dcir1−/− co-
lons (Figs. 2b, 3a). Although the production of monocyte
chemoattractant MCP-1 and several proinflammatory
cytokines, such as IFN-γ and IL-1β, tended to be lower
in Dcir1−/− colons, the difference was not statistically
significant (Fig. 3a). The production of other cytokines
was not different between the WT and Dcir1−/− colons.
We could not detect IL-12 expression. These data col-
lectively suggest that Dcir1 may accelerate neutrophil re-
cruitment through the enhanced MIP-2 production in
inflamed colons.
To exclude the possibility that Dcir1−/− neutrophils
are less competent to respond to MIP-2, the chemotactic
activity of bone marrow neutrophils was assessed using
a transwell culture system. Results showed that a lack of
Dcir1 did not affect the migration capacity of neutro-
phils in response to MIP-2 (Fig. 3b).
Decreased numbers of MPO+ neutrophils in the inflamed
colon of Dcir1−/− mice
MPO in neutrophils is involved in the production of
ROS that are involved in both host defense and tissue
injury [9, 10]. To identify the localization and numbers
of MPO+ neutrophils, we stained cryosections of the
colon using anti-MPO Ab in combination with anti-
Ly6G and -CD11b mAbs on day 5. MPO+ neutrophils
(CD11b+Ly6G+) infiltrated into the submucosal and mu-
cosal areas of the colon in colitis-induced WT mice and
Dcir1−/− mice (Fig. 4a, arrowheads). However, fewer
MPO+ neutrophils were accumulated in Dcir1−/− mice
colon than in WT mice colon (Fig. 4b). Without DSS
treatment, there was no difference in the numbers of
MPO+ neutrophils in WT and Dcir1−/− colons. These re-
sults suggest that Dcir1 in WT mice enhances the infil-
tration of activated neutrophils into the colon, which
exacerbates colitis.
Altered ROS production from Dcir1−/− neutrophils in
response to LPS stimulation in vitro
We next focused on ROS production by neutrophils
lacking Dcir1. Neutrophils were purified from bone mar-
row and stimulated with LPS (Fig. 5a). In comparison
with WT neutrophils, Dcir1−/− neutrophils produced
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lower amounts of ROS in response to LPS. However,
Dcir1−/−, but not WT, neutrophils produced more ROS
in response to GM-CSF (Fig. 5b). This is consistent with
a previous report that Dcir1 inhibited GM-CSF-
dependent signaling [20]. These results suggest that
Dcir1 enhances both infiltration of neutrophils into the
inflamed colon, and their ability to produce ROS in re-
sponse to microbes.
Discussion
Here we demonstrated that Dcir1 is involved in acute in-
testinal inflammation caused by DSS. Of note, both
Dcir1−/− and WT mice demonstrated similar body
weight changes in the early days of DSS intake; however,
Dcir1−/− mice showed attenuated body weight loss from
day 4 and a better clinical score especially in the trans-
verse and distal colon compared with WT mice on day
8. These results imply that Dcir1 enhances the progres-
sion of DSS colitis.
MIP-2 production was lower in colons from Dcir1−/−
mice on day 5 of DSS colitis, when the number of neu-
trophils reached a peak. MIP-2 expression is correlated
with the clinical activity index in human UC and murine
DSS colitis [31, 32], and its receptor, CXCR2, is a major
mediator of neutrophil influx in some disease models in-
cluding acute colitis [33, 34]. The depletion or blocking
of CXCR2 was protective against acute and chronic DSS
colitis [35, 36]. Similarly, high levels of CXCR1/2 and
CXCR1/2 ligand expression were observed in the mu-
cosa of UC patients [37]. Although we observed the nor-
mal migration of bone marrow Dcir1−/− neutrophils
toward MIP-2, we found reduced accumulation of MPO+
neutrophils in colons on day 5 of DSS colitis. Activated
neutrophils secrete MPO, resulting in mucosal disruption
and ulceration [7, 38, 39]. Therefore, our data suggest that
Dcir1 contributes to the development of intestinal inflam-
mation though the recruitment of neutrophils and their
MPO production. Furthermore, bone marrow neutrophils
from Dcir1−/− mice produced smaller amounts of ROS
compared with WT neutrophils in response to LPS. Dur-
ing colitis, the epithelial barrier is damaged, leading to in-
teractions between commensal bacteria and neutrophils.
In this situation, Dcir1−/− neutrophils may produce small
amounts of ROS compared with WT neutrophils. Com-
mensal bacteria have been implicated in the pathogenesis
of human IBD and several animal models including DSS
colitis [40–42]. Therefore, a lack of Dcir1 might also con-
tribute to ameliorating DSS colitis via the down modula-
tion of ROS production.
We also found that a lack of Dcir1 enhanced GM-CSF
signaling. Previous reports showed GM-CSF production
in the colon of UC patients and DSS colitis-induced
mice [43, 44]. The enhancement of GM-CSF signaling
possibly suppresses colitis because GM-CSF−/− mice are
more susceptible to DSS colitis [45] and GM-CSF treat-
ment results in significantly improved clinical parame-
ters and histology of DSS colitis [46]. These results
suggest that a lack of Dcir1 enhances GM-CSF signaling,
resulting in an improvement of DSS colitis. Taken to-
gether, a lack of Dcir1 causes reduced neutrophil accu-
mulation via downregulation of MIP-2 expression,
reduced ROS production and enhanced GM-CSF signal-
ing, which possibly leads to an improvement of DSS in-
duced colitis. In contrast, it is known that ROS
production increases direct bactericidal activity [47] and
neutrophil extracellular traps (NET) formation [48] by
neutrophils. Lack of Dcir1 might affect these neutrophil
functions.
We previously reported that Dcir1−/−mice tended to
develop autoimmune arthritis because of enhanced GM-
CSF signaling and DCs development [20]. Furthermore,
DCIR signaling induces the suppression of other path-
ways, such as B cell receptor signaling and proinflamma-
tory cytokine production via TLR ligands [19, 49, 50].
However, Dcir1 enhances DSS colitis via several path-
ways as described here. Therefore, the balance between
benefit and detriment caused by DCIR might be differ-
ent in various types of disease models and experimental
conditions. Recently, Hutter et al. reported no difference
in DSS colitis symptoms observed between Dcir1−/− and
WT mice [51]. It was also reported that an increased
cellular infiltration into the rectum of Dcir1−/− mice
was present at 7 days with 3 % DSS treatment. In our
study, we used a different protocol (2.0 % DSS for
5 days followed by water for 3 days) for a more moder-
ate induction of colitis, and observed an alleviation of
body weight loss in Dcir1−/− mice mainly after exchan-
ging DSS for normal water. The simplest explanation
for the different observations between studies is that
the role of Dcir1 might be different depending on the
(See figure on previous page.)
Fig. 1 Decreased susceptibility of Dcir1−/− mice to DSS colitis than WT mice. a Body weight change of WT and Dcir1−/− mice during DSS colitis is
shown. Data are representative of three independent experiments (n = 4–7 mice/group). *, #, +P < 0.05, ++P < 0.001. b Length of cecum and colon on
day 8 was measured. Cecum and colon data are representative of two (n = 3) and six (n = 15–37) independent experiments, respectively. **P < 0.01,
***P < 0.005. c Cross-sections of cecum on day 8 were observed after hematoxylin-eosin staining (magnification × 20). Scale bars represent 50 μm.
d Histological colitis scores of various parts of intestine on day 8 were indicated. Data are representative of two independent experiments (n = 3 for
cecum and n = 6 for colon). **P < 0.01, *** P < 0.005. Data are expressed as the mean ± SEM
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symptoms of DSS colitis, or their use of stronger DSS
colitis induction conditions compared with our study,
which might have negated the benefit of a lack of
Dcir1.
Conclusions
We showed that a lack of Dcir1 suppressed the develop-
ment of experimental DSS colitis. In the intestine of
Dcir1−/− mice with colitis, the number of tissue-injuring
Fig. 2 Decreased infiltration of neutrophils in Dcir1−/− mice intestine during DSS colitis. a Neutrophils (CD11b+Ly6G+) and monocytic cells
(CD11b+Ly6GlowLy6Clow, int, hi) in the intestine on day 5 after induction of DSS colitis were analyzed by flow cytometry. The numbers in
dot plots indicate the percentages of cells in the gated populations. Monocytic cells were separated into three populations dependent
upon Ly6C expression. b Numbers of neutrophils and monocytic myeloid cells during DSS colitis are shown. The populations were identified
as in (a) Results are representative of two independent experiments (n= 3). *P< 0.05. c T cells (DX5−CD3+), NKT cells (DX5+CD3+), NK cells (DX5+CD3−) and
B cells (CD3− CD19+) in the intestine on day 5 after induction of DSS colitis were analyzed by flow cytometry. d Numbers of T cells, NKT cells, NK cells and
B cells during DSS colitis were depicted. The populations were identified as in (c). Results are representative of two independent experiments (n= 3).
*P< 0.05. Data are expressed as the mean ± SEM
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Fig. 3 Decreased MIP-2 production and normal neutrophil responses in Dcir1−/− mouse colitis colon. a Chemokine and cytokine production
in organ cultures was analyzed. Tissue fragments of ceca and colons from 5 days DSS-treated mice were cultured for 24 h, and chemokine
and cytokine production was measured by CBA or ELISA. Data are the combined results of two independent experiments (n = 6). *P < 0.05.
b Chemotactic activity of neutrophils to MIP-2 was assessed using transwells. After staining with FITC-anti-Ly6G and PE-anti-CD11b, bone
marrow cells that migrated into the lower wells in the presence of 100 ng of MIP-2 were analyzed by flow cytometry after 1 h (left panels).
Data are representative of two independent experiments (n = 4) (right bar panel). Data are expressed as the mean ± SEM
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Fig. 5 Involvement of Dcir1 in the oxidative burst of neutrophils in response to LPS and GM-CSF. a Neutrophils sorted from Dcir1−/− and WT bone
marrow were stimulated with 100 ng/ml LPS for 6 h in the presence of DHR-123 for the last 30 min of culture, and conversion to rhodamine-123
(Rho-123) was assessed by flow cytometry. b ROS production of neutrophils was analyzed as in (a) after stimulation with 10 ng/ml GM-CSF for
6 h. Results are representative of two independent experiments (n = 4). ****P < 0.001. Data are expressed as the mean ± SEM
Fig. 4 Decreased numbers of MPO+ neutrophils in Dcir1−/− mice colitic colon. a The descending colons from WT and Dcir1−/− mice that were
untreated or treated with DSS for 5 days were stained with FITC-anti-Ly6G (green), anti-MPO (red) and APC-anti-CD11b (blue). Cell nuclei were
visualized using DAPI (white). Arrowheads represent cells stained with triple colors. ME: muscle externa, S: submucosa, M: mucosa. Each area is
delineated by a white dotted line. Magnification × 10. Scale bars represent 100 μm. b Numbers of MPO+ neutrophils (CD11b+Ly6G+) were
counted in vertical sections of colon from WT and Dcir1−/− mice treated as in (a) Data are the combined results of two independent experiments
(n = 3-5). *P < 0.05. Data are expressed as the mean ± SEM
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MPO+ neutrophils was lower than in WT mice, possibly
because of the down-regulation of MIP-2 chemokine.
Furthermore, bone marrow neutrophils produced re-
duced levels of ROS in response to LPS. Our results sug-
gest that Dcir1 affects the accumulation and properties
of neutrophils, and enhances the development of DSS
colitis. Further studies regarding the mechanisms con-
trolling neutrophils by DCIR will provide new clues to
understand intestinal inflammation.
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